Market Place
Sourcing Support
Takeda`s Adzynma draws FDA scrutiny after paediatric death
22 Nov 2025 //
FDA
AIOCD Asks Traders To Strictly Comply With The Ban On 35 Fdcs
21 Nov 2025 //
PHARMABIZ
NABL Sets Terms For Labs To Obtain And Keep Accreditation
21 Nov 2025 //
PHARMABIZ
Piramal Pharma Solutions` UK Site Secures Renewed MHRA GMP
21 Nov 2025 //
INDPHARMAPOST
Texas Sues Sanofi, BMS Over `Deceptive` Plavix Marketing
21 Nov 2025 //
FIERCE PHARMA
Regulator Tightens Rules on High-Risk Solvents Post Syrup Deaths
19 Nov 2025 //
ECONOMICTIMES
KSMSCL Strengthens Drug Procurement With Quarantine Measures
18 Nov 2025 //
PHARMABIZ
OTC Morning-After Pills Sold in Varying Doses with Warnings
18 Nov 2025 //
ECONOMICTIMES
Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad
17 Nov 2025 //
RAPS
AIOCD & RDCA Support Regulatory Crackdown On MTP & Narcotic Drug
17 Nov 2025 //
PHARMABIZ
Medico Remedies Receives GMP Certificate From SMDC, In Ukraine
16 Nov 2025 //
INDPHARMAPOST
Aurobindo Pharma Receives 9 Observations From USFDA For Eugia
15 Nov 2025 //
INDPHARMAPOST
Regulator Tightens Quality Checks, Threatening Small Pharma Firms
13 Nov 2025 //
ECONOMICTIMES
Omnicell Secures URAC Certification For Health System Pharmacies
13 Nov 2025 //
BUSINESSWIRE
FDA Warns Companies For GMP And Unapproved Drug Violations
13 Nov 2025 //
RAPS
Fresenius, Sun, Teva & Others Launched Drug Recalls This Fall
12 Nov 2025 //
FIERCE PHARMA
Marksans Pharma`s Goa Unit Clears FDA Inspection
10 Nov 2025 //
INDPHARMAPOST
CDSCO Orders Inspections Of MSME Pharma Units As Schedule M
09 Nov 2025 //
BUSINESS STD
Drug Regulator For Strict Compliance With New Schedule M
08 Nov 2025 //
ECONOMICTIMES
Byheart Voluntarily Recalls Two Infant Formula Batches Amid FDA
08 Nov 2025 //
BUSINESSWIRE
Vivazen Supports Kentucky`s Consumer Protection Against 7-OH
06 Nov 2025 //
BUSINESSWIRE
Fresenius Kabi Recalls 3 Lots Of Famotidine Injection
06 Nov 2025 //
BUSINESSWIRE
FDA Warns Companies On Illegal Marketing Of Botox & Related
05 Nov 2025 //
GLOBENEWSWIRE
Haryana DCA Seals 16 Sirsa Medical Shops For Illegal Drug Sales
05 Nov 2025 //
PHARMABIZ
Odisha Ex-Dc Proposes Landmark Guidelines For Spurious Drug
03 Nov 2025 //
PHARMABIZ
FDA Issues Draft Guidance On QMSR Information For Premarket
03 Nov 2025 //
RAPS
FDA Warns Four Firms For Unapproved Children`s Fluoride Drugs
31 Oct 2025 //
REUTERS
FDA Warns Philips for Manufacturing and Quality System Issues
31 Oct 2025 //
INDPHARMAPOST
Centre Drafts Rules To Ban Drugmakers For Providing False Inform
29 Oct 2025 //
BUSINESS STD
Drug Company Forging Data for, Mislabelled Brand to Be Barred
29 Oct 2025 //
ECONOMICTIMES
IPC to Host TB Elimination Stakeholder Meet on October 30
28 Oct 2025 //
PHARMABIZ
Nextgen Bio Passes Initial FDA Audit With No Observations
28 Oct 2025 //
GLOBENEWSWIRE
SK Pharmteco Earn Top My Green Lab Certifications In Europe, Asia
28 Oct 2025 //
BUSINESSWIRE
Pharmas Hope FDA PreCheck Can Help Avoid Facility Drug Rejections
28 Oct 2025 //
BIOSPACE
Haryana DC Introduces Digital System To Monitor High-Risk Solvent
28 Oct 2025 //
PHARMABIZ
FDA Official Issues Warning About Looming Biosimilar Void
28 Oct 2025 //
RAPS
FDA Rejects Eylea HD For Ongoing Manufacturing Issues
28 Oct 2025 //
FIERCE PHARMA
PvPI Detects 16 India-Specific Signals, 183 Drug Safety Alerts
27 Oct 2025 //
PHARMABIZ
CDSCO Releases 1,700 Standards For Medical Equipment Compliance
27 Oct 2025 //
PHARMABIZ
India Progresses Anti-Dumping Probe On TB Drug Imports
27 Oct 2025 //
REUTERS
Magellan Diagnostics Ex-CEO Escapes Prison For Test Device Defect
27 Oct 2025 //
REUTERS
FDA Warns Chinese And Swiss Device Makers For Quality Violations
24 Oct 2025 //
RAPS
Lethal Batch Of Coldrif Cough Syrup Dispensed In Pondicherry
24 Oct 2025 //
PHARMABIZ
CDSCO Implements Digital Monitoring On ONDLS Portal
24 Oct 2025 //
PHARMABIZ
CDSCO Introduces Digital Tracker For High-Risk Solvents In Cough
23 Oct 2025 //
BUSINESS STD
Central Drugs Laboratories Detect 52 Substandard Drug Samples
23 Oct 2025 //
ECONOMICTIMES
CS Analytical Expands USP 661.1 Service With HPLC & GC
22 Oct 2025 //
PR NEWSWIRE
FDA Warns Eye Drop Firms In US And Australia For GMP Violations
21 Oct 2025 //
RAPS
Dr. Reddy`s Srikakulam Unit Voluntarily Classified By USFDA
21 Oct 2025 //
ECONOMICTIMES
Ascendis Skids As FDA Detects Death In Patient On Yorvipath
21 Oct 2025 //
BIOSPACE
New ICH Q1 guideline is ‘one-stop shop’ for stability testing
20 Oct 2025 //
RAPS
TGA Proposes GMP Exemption To Aid Bacteriophage developers
20 Oct 2025 //
RAPS
Glenmark Recalls Product In US Over Manufacturing Issue: USFDA
19 Oct 2025 //
ECONOMICTIMES
RDCA Warns Chemist To Comply With Pharmacy Act After DPC Circular
18 Oct 2025 //
PHARMABIZ
Unpacking The FDA Transparency Push On Crls
17 Oct 2025 //
FIERCE BIOTECH
India to Drugmakers to Upgrade Plants After Cough Syrup Crisis
17 Oct 2025 //
REUTERS
Haryana State Drug Controller Expands Toxic Impurity Alert
16 Oct 2025 //
PHARMABIZ
India Pharma Regulatory Failures Highlight Structural Issue
16 Oct 2025 //
BUSINESS STD
Government To Enforce Law For Rigorous Quality Checks On Drugs
15 Oct 2025 //
ECONOMICTIMES
J&J Faces First UK Lawsuits Over Baby Powder Cancer Link
15 Oct 2025 //
REUTERS
